Lahar Mehta

Lahar Mehta has a diverse work experience in the pharmaceutical and medical fields. Their most recent role was as the Vice President/Head of Global Clinical Development at Amylyx Pharmaceuticals, starting in October 2021. Prior to that, they served as the Vice President of Clinical Development at Annexon Biosciences from September 2020 to November 2021. Lahar also held positions as the Vice President of Clinical Development at Alder Biopharmaceuticals/Lundbeck Seattle Biopharmaceuticals from May 2019 to September 2020, Senior Medical Director at Genentech from July 2018 to May 2019, and Medical Director at Amgen from June 2016 to July 2018. Before joining these companies, they worked at Biogen as a Medical Director in Clinical Development from February 2014 to June 2016 and as an Associate Medical Director in Clinical Development from March 2012 to February 2014. Prior to that, Lahar was a Clinical Neurologist and Consultant at Evergreen Neuroscience Institute from May 2009 to March 2012 and an Instructor in Neurology at the University of Rochester Medical Center from January 2007 to March 2009. They also served as a Chief Resident at the University of Utah Hospitals and Clinics from 2005 to 2006. Lahar began their career as a Medical Officer in the United States Navy from 1999 to 2003.

Lahar Mehta completed a BS in Business Administration from Washington University in St. Louis from 1990 to 1994. They then pursued a Doctor of Medicine (M.D.) from Meharry Medical College, which they completed from 1995 to 1999. Following this, Lahar Mehta went on to do a General Surgery Internship at Naval Medical Center San Diego from 1999 to 2000. They furthered their education by completing a Neurology Residency Program at the University of Utah School of Medicine from 2003 to 2006. Finally, they pursued a Fellowship in Experimental Therapeutics and Neuroimmunology at the University of Rochester from 2007 to 2009.